The recall involves Veklury for Injection with Lot #47035CFA (NDC # 61958-2901-02) and an expiration date of November 2025. Gilead is voluntarily recalling 1 lot of Veklury ® (remdesivir) for ...
Lugano, Switzerland – June 24, 2024 – Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of over forty-five years of commercial execution and a strong focus in supportive ...
Exela Pharma Sciences is recalling an additional 14 lots of Sodium Bicarbonate Injection, USP, 8.4%, 50mEq/50 mL vial, 20-count carton. In total, the Company is recalling 63 lots of the product due to ...
Gilead Sciences recently announced a voluntary recall of one lot of its Veklury (remdesivir) for injection 100 mg/vial, to the consumer level, after confirming the presence of a glass particle in the ...
Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic ...
(RTTNews) - Amphastar Pharmaceuticals Inc. (AMPH) announced Tuesday that the U.S. Food and Drug Administration has approved its Abbreviated New Drug Application or ANDA for Succinylcholine Chloride ...
Glenmark Pharmaceuticals Inc., USA (Glenmark), a research-led, global pharmaceutical company, announces the launch of vancomycin hydrochloride for injection USP, 750 mg/vial, 1.25 g/vial and 1.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback